ATRC vs CAH · rev $294.9M vs P/E 35, rev $254.25B
AtriCure Inc (ATRC) versus Cardinal Health Inc (CAH) — a side-by-side from cached financials, not a winner call.
AtriCure Inc (ATRC) is a medical instruments & supplies company listed on US.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Latest reported ATRC revenue for 2026-06-30 was $294.9M. Net income was $9.1M. ATRC currently screens at market cap $1.37B.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
ATRC currently screens at market cap $1.37B. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Not investment advice. Open the ATRC and CAH stock pages for the full models.
Not investment advice.